近年来上海医院治疗良性前列腺增生药物的应用分析

Analysis of the drugs used for benign prostatic hyperplasia in 119 hospitals of Shanghai during the period 2008-2010

目的:了解最近3年来上海医院治疗良性前列腺增生(BPH)药物应用的情况。方法:调研上海市119家样本医院2008-2010年治疗BPH药物主要品种的金额、用量、用药频度(DDDS)和增长率以及临床用药评价。结果:非那雄胺、坦洛新、多沙唑嗪、普适泰和特拉唑嗪占市场主导地位。结论:治疗BPH药物的市场潜力很大。

Objective：To get a clear information about the situation of application of benign prostatic hyperplasia （BPH） in hospitals of Shanghai so as to provide data for departments of production,sale and consumption.Methods：To investigate the BPH drugs used in 119 hospitals of Shanghai during the 2008-2010 period in respect to the amount of consumption,kinds,sum of money of consumption,DDDs and clinical evaluation.Results：Finasteride,tamsulosin,doxazosin,prostat and terazosin were the most commonly used drugs.Conclusion：To speed up the research and development of drugs in our country.